TGF beta 1 Mouse Monoclonal Antibody (MDB0108AB)

Overview
The TGF Beta 1 Mouse Monoclonal Antibody (MDB0108AB) is a high-affinity, unconjugated antibody specifically designed for the detection of Transforming Growth Factor Beta 1 (TGF-β1) in human, mouse, rat, and rabbit samples. Generated against a KLH-conjugated synthetic peptide derived from human TGF beta 1 and purified by peptide affinity chromatography, this antibody is validated across multiple applications including Western Blot, ELISA, Immunocytochemistry, Immunofluorescence, and Immunohistochemistry (paraffin-embedded sections). It is an essential tool for research in fibrosis, cancer biology, immunology, and developmental biology.

Applications
Ideal for:

• Fibrosis and tissue remodeling studies

• Cancer progression and tumor microenvironment research

• Immune regulation and autoimmune disease models

• Developmental biology and cell differentiation

• Wound healing and extracellular matrix research

Why Choose This Antibody?

• High Specificity: Recognizes TGF beta 1 with minimal cross-reactivity

• Broad Species Reactivity: Human, mouse, rat, and rabbit validated

• Multiple Application Validation: IHC, IF, WB, ELISA, and ICC

• Extensive Tissue Validation: Liver, skin, brain, kidney, intestine, and more

• Trusted Performance: Peptide affinity purified for consistent, reproducible results

Market Leader Advantage
Trusted by leading fibrosis, cancer, and immunology research laboratories worldwide, the MDB0108AB antibody delivers publication-ready results. Whether you are studying TGF-β1 signaling in fibrosis, tumor progression, or immune regulation, this antibody provides the sensitivity and specificity you need for reliable, reproducible data.

Note: For research use only. Not for diagnostic or therapeutic use.